- Report
- July 2024
- 155 Pages
Global
From €4035EUR$4,250USD£3,403GBP
- Report
- April 2022
- 190 Pages
Global
From €3384EUR$3,565USD£2,855GBP
- Book
- March 2019
- 648 Pages
- Book
- April 2016
- 576 Pages
- Book
- December 2014
- 280 Pages
- Book
- August 2011
- 572 Pages
- Book
- March 2009
- 516 Pages
- Book
- September 2017
North America
Gynecological cancer is a type of cancer that affects the female reproductive system, including the uterus, cervix, ovaries, fallopian tubes, vagina, and vulva. It is the second most common type of cancer among women, and the most common cause of death from gynecological cancer is cervical cancer. Treatment for gynecological cancer typically involves surgery, chemotherapy, and radiation therapy.
Women's health is an important area of focus for gynecological cancer, as it is a major cause of death among women. Early detection and treatment are key to reducing the mortality rate of gynecological cancer, and women should be aware of the signs and symptoms of gynecological cancer. Regular screenings and preventive measures are also important for reducing the risk of developing gynecological cancer.
There are a number of companies in the gynecological cancer market, including Roche, Novartis, AstraZeneca, Merck, and Pfizer. These companies are involved in the development of treatments and therapies for gynecological cancer, as well as in the research and development of new treatments and therapies. Show Less Read more